vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and enCore Energy Corp. (EU). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $12.4M, roughly 1.5× enCore Energy Corp.). Apyx Medical Corp runs the higher net margin — -6.8% vs -173.9%, a 167.1% gap on every dollar of revenue. enCore Energy Corp. produced more free cash flow last quarter ($7.2M vs $-2.8M).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.
APYX vs EU — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $12.4M |
| Net Profit | $-1.3M | $-21.5M |
| Gross Margin | 62.6% | 37.9% |
| Operating Margin | 0.1% | -135.9% |
| Net Margin | -6.8% | -173.9% |
| Revenue YoY | 34.7% | — |
| Net Profit YoY | 71.9% | — |
| EPS (diluted) | — | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $12.4M | ||
| Q3 25 | $12.9M | $8.9M | ||
| Q2 25 | $11.4M | $3.7M | ||
| Q1 25 | $9.4M | $18.2M | ||
| Q4 24 | $14.2M | — | ||
| Q3 24 | $11.5M | — | ||
| Q2 24 | $12.1M | — | ||
| Q1 24 | $10.2M | — |
| Q4 25 | $-1.3M | $-21.5M | ||
| Q3 25 | $-2.0M | $-4.8M | ||
| Q2 25 | $-3.8M | $-6.3M | ||
| Q1 25 | $-4.2M | $-24.2M | ||
| Q4 24 | $-4.6M | — | ||
| Q3 24 | $-4.7M | — | ||
| Q2 24 | $-6.6M | — | ||
| Q1 24 | $-7.6M | — |
| Q4 25 | 62.6% | 37.9% | ||
| Q3 25 | 64.4% | 43.8% | ||
| Q2 25 | 62.3% | 30.8% | ||
| Q1 25 | 60.1% | -0.1% | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | -135.9% | ||
| Q3 25 | -6.5% | -158.2% | ||
| Q2 25 | -22.6% | -526.1% | ||
| Q1 25 | -32.4% | -85.7% | ||
| Q4 24 | -21.4% | — | ||
| Q3 24 | -31.6% | — | ||
| Q2 24 | -45.7% | — | ||
| Q1 24 | -64.6% | — |
| Q4 25 | -6.8% | -173.9% | ||
| Q3 25 | -15.4% | -53.7% | ||
| Q2 25 | -33.2% | -172.7% | ||
| Q1 25 | -44.0% | -132.9% | ||
| Q4 24 | -32.5% | — | ||
| Q3 24 | -40.9% | — | ||
| Q2 24 | -54.0% | — | ||
| Q1 24 | -74.0% | — |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | — | $-0.13 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-0.19 | — | ||
| Q1 24 | $-0.22 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $52.4M |
| Total DebtLower is stronger | $37.5M | $110.0M |
| Stockholders' EquityBook value | $14.5M | $229.2M |
| Total Assets | $66.8M | $430.4M |
| Debt / EquityLower = less leverage | 2.58× | 0.48× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $52.4M | ||
| Q3 25 | $25.1M | $91.9M | ||
| Q2 25 | $29.3M | $26.9M | ||
| Q1 25 | $31.0M | $29.7M | ||
| Q4 24 | $31.7M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $32.7M | — | ||
| Q1 24 | $37.3M | — |
| Q4 25 | $37.5M | $110.0M | ||
| Q3 25 | $37.5M | $109.3M | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $229.2M | ||
| Q3 25 | $5.8M | $248.6M | ||
| Q2 25 | $7.3M | $264.7M | ||
| Q1 25 | $10.5M | $267.9M | ||
| Q4 24 | $14.2M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $14.7M | — | ||
| Q1 24 | $20.3M | — |
| Q4 25 | $66.8M | $430.4M | ||
| Q3 25 | $57.4M | $441.9M | ||
| Q2 25 | $58.2M | $359.4M | ||
| Q1 25 | $60.2M | $362.6M | ||
| Q4 24 | $64.8M | — | ||
| Q3 24 | $60.7M | — | ||
| Q2 24 | $65.4M | — | ||
| Q1 24 | $70.7M | — |
| Q4 25 | 2.58× | 0.48× | ||
| Q3 25 | 6.41× | 0.44× | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $12.9M |
| Free Cash FlowOCF − Capex | $-2.8M | $7.2M |
| FCF MarginFCF / Revenue | -14.6% | 57.8% |
| Capex IntensityCapex / Revenue | 1.4% | 46.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $-45.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $12.9M | ||
| Q3 25 | $-3.5M | $-20.3M | ||
| Q2 25 | $-1.2M | $-9.9M | ||
| Q1 25 | $-702.0K | $-7.7M | ||
| Q4 24 | $-2.9M | — | ||
| Q3 24 | $-4.4M | — | ||
| Q2 24 | $-4.3M | — | ||
| Q1 24 | $-6.3M | — |
| Q4 25 | $-2.8M | $7.2M | ||
| Q3 25 | $-4.1M | $-26.3M | ||
| Q2 25 | $-1.5M | $-14.1M | ||
| Q1 25 | $-757.0K | $-11.7M | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
| Q4 25 | -14.6% | 57.8% | ||
| Q3 25 | -31.5% | -296.6% | ||
| Q2 25 | -13.2% | -385.2% | ||
| Q1 25 | -8.0% | -64.1% | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
| Q4 25 | 1.4% | 46.7% | ||
| Q3 25 | 4.0% | 68.0% | ||
| Q2 25 | 2.3% | 115.1% | ||
| Q1 25 | 0.6% | 21.7% | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
